BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8946914)

  • 21. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity.
    Salomoni P; Perrotti D; Martinez R; Franceschi C; Calabretta B
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3296-301. PubMed ID: 9096387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
    Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
    Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism.
    Hueber AO; Raposo G; Pierres M; He HT
    J Exp Med; 1994 Mar; 179(3):785-96. PubMed ID: 7906706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.
    Bouillet P; Purton JF; Godfrey DI; Zhang LC; Coultas L; Puthalakath H; Pellegrini M; Cory S; Adams JM; Strasser A
    Nature; 2002 Feb; 415(6874):922-6. PubMed ID: 11859372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.
    Venturelli D; Travali S; Calabretta B
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5963-7. PubMed ID: 1696013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical interaction between retinoic acid receptor and the oncoprotein myb inhibits retinoic acid-dependent transactivation.
    Pfitzner E; Kirfel J; Becker P; Rolke A; Schüle R
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5539-44. PubMed ID: 9576918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression.
    Sumitani K; Kamijo R; Nagumo M
    Anticancer Res; 1997; 17(2A):865-71. PubMed ID: 9137419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
    Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
    Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB.
    Postigo AA; Sheppard AM; Mucenski ML; Dean DC
    EMBO J; 1997 Jul; 16(13):3924-34. PubMed ID: 9233802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.
    Carrio R; Lopez DM
    Int J Mol Med; 2009 Jan; 23(1):89-98. PubMed ID: 19082511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
    J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells.
    Corradini F; Bussolari R; Cerioli D; Lidonnici MR; Calabretta B
    Blood Cells Mol Dis; 2007; 39(3):292-6. PubMed ID: 17644012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chicken A-myb protein is a transcriptional activator.
    Foos G; Grimm S; Klempnauer KH
    Oncogene; 1994 Sep; 9(9):2481-8. PubMed ID: 8058311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.
    Wen R; Wang D; McKay C; Bunting KD; Marine JC; Vanin EF; Zambetti GP; Korsmeyer SJ; Ihle JN; Cleveland JL
    Mol Cell Biol; 2001 Jan; 21(2):678-89. PubMed ID: 11134353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gag-Myb-Ets fusion oncogene alters the apoptotic response and growth factor dependence of interleukin-3 dependent murine cells.
    Athanasiou M; Mavrothalassitis GJ; Yuan CC; Blair DG
    Oncogene; 1996 Jan; 12(2):337-44. PubMed ID: 8570210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.
    Sandberg ML; Sutton SE; Pletcher MT; Wiltshire T; Tarantino LM; Hogenesch JB; Cooke MP
    Dev Cell; 2005 Feb; 8(2):153-66. PubMed ID: 15691758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.
    Matre V; Høvring PI; Fjeldheim AK; Helgeland L; Orvain C; Andersson KB; Gautvik KM; Gabrielsen OS
    Biochem J; 2003 Jun; 372(Pt 3):851-9. PubMed ID: 12628004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
    Miglarese MR; Halaban R; Gibson NW
    Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.